SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-039153
Filing Date
2023-08-07
Accepted
2023-08-07 17:02:56
Documents
18
Period of Report
2023-09-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A tcon-20230803.htm   iXBRL DEF 14A 294642
2 GRAPHIC img19860969_0.jpg GRAPHIC 11404
3 GRAPHIC img19860969_1.jpg GRAPHIC 14757
4 GRAPHIC img19860969_2.jpg GRAPHIC 14757
5 GRAPHIC img19860969_3.jpg GRAPHIC 65398
6 GRAPHIC img19860969_4.jpg GRAPHIC 793651
  Complete submission text file 0000950170-23-039153.txt   2605907

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230803_lab.xml EX-101.LAB 3164
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230803.xsd EX-101.SCH 2476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230803_pre.xml EX-101.PRE 2774
11 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230803_htm.xml XML 1305
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36818 | Film No.: 231148363
SIC: 2836 Biological Products, (No Diagnostic Substances)